CapeStart Closes 2024 with New Client Growth, Strategic Hires, and the Launch of MadeAi™, the Award-winning GenAI-enabled Platform
A Banner Year for the Life Sciences GenAI Services and Solutions Provider Brings AI Innovation, Staff Growth, and Life Science Advancement
CAMBRIDGE, MA, January 27, 2025—CapeStart, an industry leader in AI services and solutions, enjoyed another year of innovation, AI platform evolution, and growth, marked by strategic hires to support its ever-growing AI expert team. CapeStart added new, large pharmaceutical and medical device companies to its community of marquee clients, supporting these healthcare and life sciences organizations with leading-edge innovation in GenAI that helps them improve research, clinical content synthesis, and ultimately deliver better patient outcomes.
Significant investments in AI excellence have strengthened CapeStart’s seasoned team, including the addition of numerous life science subject matter experts and AI specialists. Further bolstering CapeStart’s commitment to life science customers, CapeStart also recruited market expert Meghan Oates-Zalesky as Chief Marketing Officer. Oates-Zalesky brings two decades of healthcare and life science business, market, and commercialization experience to CapeStart, including her most recent role at Apollo Intelligence, leading the brand and market position of the company through multiple acquisitions.
CapeStart’s 2024 achievements included:
Growth—Over 10 new brands were added to CapeStart’s client list in 2024 to close out the year. Capestart’s client base now includes six of the world’s top 20 pharmaceutical manufacturers.
MadeAi Launch—CapeStart launched the MadeAi platform debuting its first use case supporting systematic literature review (SLR) for life sciences with MadeAi-LR. In addition to SLR support, CapeStart envisions future MadeAi platform offerings with global value dossier, pharmacovigilance, and clinical content generation—all leveraging the foundational MadeAi platform to synthesize large amounts of data and content, accelerating otherwise manual content synthesis, analysis, and summarization.
Awards—including a Stevie® award in the 21st Annual International Business Awards® program, where CapeStart’s MadeAi platform was recognized as an innovative Artificial Intelligence/Machine Learning Solution in Healthcare within the Business Technology category. MadeAi was also included among PM360’s most innovative solutions in 2024. CapeStart received an Exceptional Employee Experience Award from HRWorld by the Economic Times and a Most-Preferred Workplace award from Marksmen Daily.
“Our growth in 2024 has been a testament to the commitment of our team members. We’re looking forward to a strong 2025, continuing to bring innovation and value to our clients,” said Gaugarin Oliver, CEO and Founder of CapeStart. “The launch of our MadeAi platform marks years of AI development experience and life science subject matter expertise that will further evolve to support our clients’ changing needs.”
About CapeStart
CapeStart helps organizations compete and win in the AI economy. Its AI solutions, including a GenAI-enabled life science platform, bring the efficiency of AI to life science firms, while maintaining essential human oversight. CapeStart’s skilled data experts and software developers provide complex data annotation, ML and AI model development, and software development services to healthcare, finance, and retail companies, among others. Based in Cambridge, MA, CapeStart serves 100+ clients with 600+ resources across North America, the Middle East, and Asia. For more visit www.capestart.com.
Media Contacts:
Meghan Oates-Zalesky
Chief Marketing Officer for CapeStart
Meghan.Oates@capestart.com
617-435-2470
Mary Kae Marinac
PR Representative for CapeStart
mk@mkmarinac.com
978-685-3136